Related Experiment Video
Updated: Jan 8, 2026
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Is Major Pathologic Response the Best Surrogate End Point for Neoadjuvant Trials?
Gavitt A Woodard1, Brendon M Stiles1
1Gavitt A. Woodard, MD, Division of Thoracic Surgery, Department of Surgery, Yale School of Medicine, New Haven, CT, Brendon M. Stiles, MD, Division of Thoracic Surgery, Department of Cardiothoracic and Vascular Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY.
No abstract available in PubMed .
More Related Videos
08:29Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Published on: October 2, 2014
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020